Premium
DNA binding protein dbpA binds Cdk5 and inhibits its activity
Author(s) -
Moorthamer Mark,
Zumstein-Mecker Sabine,
Chaudhuri Bhabatosh
Publication year - 1999
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(99)00248-3
Subject(s) - cyclin dependent kinase , biology , cyclin dependent kinase 5 , microbiology and biotechnology , cyclin dependent kinase 2 , cyclin , kinase , cell cycle , protein kinase a , biochemistry , cell
Progress in the cell cycle is governed by the activity of cyclin dependent kinases (Cdks). Unlike other Cdks, the Cdk5 catalytic subunit is found mostly in differentiated neurons. Interestingly, the only known protein that activates Cdk5 (i.e. p35) is expressed solely in the brain. It has been suggested that, besides its requirement in neuronal differentiation, Cdk5 activity is induced during myogenesis. However, it is not clear how this activity is regulated in the pathway that leads proliferative cells to differentiation. In order to find if there exists any Cdk5‐interacting protein, the yeast two‐hybrid system was used to screen a HeLa cDNA library. We have determined that a C‐terminal 172 amino acid domain of the DNA binding protein, dbpA, binds to Cdk5. Biochemical analyses reveal that this fragment (dbpA(CΔ)) strongly inhibits p35‐activated Cdk5 kinase. The protein also interacts with Cdk4 and inhibits the Cdk4/cyclin D1 enzyme. Surprisingly, dbpA(CΔ) does not bind Cdk2 in the two‐hybrid assay nor does it inhibit Cdk2 activated by cyclin A. It could be that dbpA's ability to inhibit Cdk5 and Cdk4 reflects an apparent cross‐talk between distinct signal transduction pathways controlled by dbpA on the one hand and Cdk5 or Cdk4 on the other.